Literature DB >> 1086285

Lymphocyte responses to phytohaemagglutinin: age-related effects.

L A Fernandez, J M MacSween, G R Langley.   

Abstract

Cell-mediated immunity is depressed in elderly individuals compared to young individuals, and lymphocytes from elderly individuals have been reported to have impaired lymphocyte responsiveness to stimulation by PHA after 4 days of culture. We have confirmed this observation. However, after 8 days of culture, the lymphocyte responses were greater in elderly normal individuals than in young normal individuals. Responses of lymphocytes from young individuals decreased with time from 4 to 8 days in culture, while there were increased responses with time when lymphocytes from elderly individuals were studied. When adherent cells from lymphocytes of young individuals were removed by passage through protein-coated Degalan-bead columns, the lymphocyte responses to PHA were significantly increased at 8 days. Passage of lymphocytes from elderly individuals through coated Degalan bead columns did not alter the lymphocyte responses. Removal of macrophages from the mononuclear cells obtained from young individuals did not result in increased lymphocyte responses to PHA after 8 days in culture. Removal of adherent cells appeared to have the same effect regardless of the efficiency of removing B cells. The adherent cells removed by the protein coated columns, therefore, appear to be nonphagocytic mononuclear cells which are not B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086285      PMCID: PMC1445368     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  Age-related changes, including synergy and suppression, in the mixed lymphocyte reaction in long-lived mice.

Authors:  M Gerbase-DeLima; P Meredith; R L Walford
Journal:  Fed Proc       Date:  1975-02

2.  Regulation of lymphocyte responses in vitro. 3. Inhibition by adherent cells of the T-lymphocyte response to phytohemagglutinin.

Authors:  H Folch; M Yoshinaga; B H Waksman
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

3.  Ageing, immune response, and mortality.

Authors:  I C Roberts-Thomson; S Whittingham; U Youngchaiyud; I R Mackay
Journal:  Lancet       Date:  1974-08-17       Impact factor: 79.321

4.  The splenic suppressor cell. I. Activity of thymus-dependent adherent cells: changes with age and stress.

Authors:  H Folch; B H Waksman
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  Phytomitogen responses of peripheral blood lymphocytes in young and older subjects.

Authors:  B S Foad; L E Adams; Y Yamauchi; A Litwin
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

6.  Rosette formation by peripheral lymphocytes.

Authors:  P Brain; J Gordon; W A Willetts
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

7.  Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.

Authors:  L A Fernandez; J M MacSween; G R Langley
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

8.  Suppressor T cells in the regulation of the immune response.

Authors:  R W Dutton; J Scavulli
Journal:  J Reticuloendothel Soc       Date:  1975-03

9.  Impaired lymphocyte function in aged humans.

Authors:  M E Weksler; T H Hütteroth
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  10 in total

1.  Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.

Authors:  C H Ten Napel; T H The; J Van Egten-Bijker; G C de Gast; M R Halie; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

2.  Development of antigen-induced proliferative responsiveness by murine lymph node cells. I. Identification of differences in the in vitro proliferative responses during a first and a second period of responsiveness.

Authors:  E Brummer; H S Lawrence
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

3.  Age-dependent changes of human blood lymphocyte subpopulations.

Authors:  J Clot; E Charmasson; J Brochier
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

4.  Reduced lymphocyte colony formation with age.

Authors:  S J Alder; A A Morley; R S Seshadri
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

5.  Human lymphocyte culture: intrinsic factors influencing the quality of chromosome preparations.

Authors:  J P Chaudhuri; E Ludwig; C Labouvie
Journal:  Blut       Date:  1977-09-29

6.  Age-related effects on the number of human lymphocytes in culture initially responding to an antigenic stimulus.

Authors:  P G Sohnle; C Collins-Lech; K E Huhta
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

7.  Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients.

Authors:  M B Constantian
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

8.  Autoantibodies to a regulatory T cell subset in human ageing.

Authors:  A J Strelkauskas; J A Andrew; E J Yunis
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

9.  Immunological studies of Aging. III. Cytokinetic basis for the impaired response of lymphocytes from aged humans to plant lectins.

Authors:  B Inkeles; J B Innes; M M Kuntz; A S Kadish; M E Weksler
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

10.  Cytokinetic analysis of the impaired proliferative response of peripheral lymphocytes from aged humans to phytohemagglutinin.

Authors:  R R Tice; E L Schneider; D Kram; P Thorne
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.